Anna Claudia Cunha
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Anna Claudia Cunha has a total of 372 co-authors. Here are the top co-authors by number of shared publications:
- Vitor Francisco Ferreira
Programa de Pós-Graduação em Ciências Aplicadas a Produtos para a Saúde, Faculdade de Farmácia, Universidade Federal Fluminense, Niterói 24241-000, RJ, Brazil
59 shared publications - Maria Cecilia Bastos Vieira de Souza
Instituto de Química, Universidade Federal Fluminense, Niterói 24020-141, RJ, Brazil
39 shared publications Alessandro K. Jordão
B University Unit of Pharmacy, State University of the West Zone , Rio de Janeiro , RJ , Brazil
19 shared publications- Helena Carla Castro
Universidade Federal Fluminense, Hospital Universitário Antônio Pedro, Programa de Pós-graduação em Patologia, 24033-900 Niterói, RJ, Brazil; Universidade Federal Fluminense, Instituto de Biologia, Programa de Pós-graduação em Ciências e Biotecnologia, CEP 24210-130, Niterói, RJ, Brazil
15 shared publications - Vinicius Rangel Campos
Institute of Chemistry, Department of Organic Chemistry, Campus do Valonguinho, Universidade Federal Fluminense, Niterói 24020-150, RJ, Brazil
15 shared publications Carlos R. Rodrigues
ModMolQSAR, Faculdade de Farmácia, UFRJ, Universidade Federal do Rio de Janeiro, Ilha do Fundão, Rio de Janeiro, Brazil
7 shared publications
Latest Publications
- Open Access
- 8 October 2025
- Published by Wiley in The Chemical Record
- Vol. 25 (12) , e2500121
Chemistry, Applications, and Synthesis Methods of Indole Derivatives: A Comprehensive Review
Indole and its derivatives represent a crucial class of heterocyclic compounds with broad applications in pharmaceuticals, agrochemicals, and materials science. The indole core is a fundamental structural motif in numerous biologically active natural products, including alkaloids, as well as synthetic molecules exhibiting diverse pharmacological properties such as anticancer, antimicrobial, anti‐inflammatory, and antiviral activities. This review concisely addresses the biosynthesis of the indole nucleus and highlights several noteworthy derivatives, including tryptophan, indigo, and indole‐3‐carbinol, among others. It explores the chemistry of indole derivatives, emphasizing their multidisciplinary relevance, and substantial impact across various fields of scientific research. Furthermore, the review discusses both classical and contemporary synthetic methodologies for constructing the indole framework, with an emphasis on sustainable approaches aligned with green chemistry principles.
- 8 October 2025
- Published by Wiley in The Chemical Record
- Vol. 25 (12) , e2500121
Open AccessChemistry, Applications, and Synthesis Methods of Indole Derivatives: A Comprehensive Review
Indole and its derivatives represent a crucial class of heterocyclic compounds with broad applications in pharmaceuticals, agrochemicals, and materials science. The indole core is a fundamental structural motif in numerous biologically active natural products, including alkaloids, as well as synthetic molecules exhibiting diverse pharmacological properties such as anticancer, antimicrobial, anti‐inflammatory, and antiviral activities. This review concisely addresses the biosynthesis of the indole nucleus and highlights several noteworthy derivatives, including tryptophan, indigo, and indole‐3‐carbinol, among others. It explores the chemistry of indole derivatives, emphasizing their multidisciplinary relevance, and substantial impact across various fields of scientific research. Furthermore, the review discusses both classical and contemporary synthetic methodologies for constructing the indole framework, with an emphasis on sustainable approaches aligned with green chemistry principles.
- 16 January 2025
- Published by Wiley in The Chemical Record
- Vol. 25 (1)
Cover Feature: A Review on Chemistry and Methods of Synthesis of 1,2,4‐Triazole Derivatives (Chem. Rec. 1/2025)
- 16 January 2025
- Published by Wiley in The Chemical Record
- Vol. 25 (1)
Cover Feature: A Review on Chemistry and Methods of Synthesis of 1,2,4‐Triazole Derivatives (Chem. Rec. 1/2025)
- 14 November 2024
- Published by Wiley in The Chemical Record
- Vol. 25 (1) , e202400190
A Review on Chemistry and Methods of Synthesis of 1,2,4‐Triazole Derivatives
This review provides a comprehensive overview of research on 1,2,4‐triazoles conducted over the last fifteen years. 1,2,4‐Triazoles are highly significant in the pharmaceutical industry, with numerous compounds from this class used clinically as antifungal, antiviral, antibacterial, anti‐inflammatory, and antitubercular agents. Beyond their pharmaceutical relevance, this review also explores their role in material science and agriculture. In material science, 1,2,4‐triazoles are gaining prominence, particularly in the development of energetic materials (EMs), due to their exceptional properties such as thermal stability, coordination ability, and performance comparable to well‐known explosives. Their applications extend to polymers, corrosion inhibitors, and metal‐organic frameworks (MOFs), and they play a significant role in the development of functional materials for sensors, catalysis, and energy storage. Additionally, the review addresses general aspects and synthetic methodologies for the functionalization and construction of the 1,2,4‐triazole ring. Synthetic methods discussed include metalation synthesis, cyclization of hydrazine derivatives, multicomponent reactions, cyclization of amides and amidines, and microwave‐assisted synthesis. Given the significance of the triazole scaffold, its synthesis has garnered considerable attention due to its wide‐ranging applications across various industrial sectors.
- 14 November 2024
- Published by Wiley in The Chemical Record
- Vol. 25 (1) , e202400190
A Review on Chemistry and Methods of Synthesis of 1,2,4‐Triazole Derivatives
This review provides a comprehensive overview of research on 1,2,4‐triazoles conducted over the last fifteen years. 1,2,4‐Triazoles are highly significant in the pharmaceutical industry, with numerous compounds from this class used clinically as antifungal, antiviral, antibacterial, anti‐inflammatory, and antitubercular agents. Beyond their pharmaceutical relevance, this review also explores their role in material science and agriculture. In material science, 1,2,4‐triazoles are gaining prominence, particularly in the development of energetic materials (EMs), due to their exceptional properties such as thermal stability, coordination ability, and performance comparable to well‐known explosives. Their applications extend to polymers, corrosion inhibitors, and metal‐organic frameworks (MOFs), and they play a significant role in the development of functional materials for sensors, catalysis, and energy storage. Additionally, the review addresses general aspects and synthetic methodologies for the functionalization and construction of the 1,2,4‐triazole ring. Synthetic methods discussed include metalation synthesis, cyclization of hydrazine derivatives, multicomponent reactions, cyclization of amides and amidines, and microwave‐assisted synthesis. Given the significance of the triazole scaffold, its synthesis has garnered considerable attention due to its wide‐ranging applications across various industrial sectors.
- 14 October 2024
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 16 (21) , 2247-2261
Synthesis and evaluation of antibacterial and antibiofilm agents based on phenylamino-substituted 1,4-benzoquinones
Aim: This work describes the synthesis and antimicrobial evaluation of 6-aminated 1,4-benzoquinones (6-AQs) against seven resistant pathogens. Materials & methods: The 6-AQs, synthesized via a Michael addition reaction between bromoquinone and p-substituted anilines, were assessed for their antimicrobial activity through both in vitro and in silico analyses. Results: Bromoquinone and 6-AQs with electron-withdrawing groups demonstrated activity against Pseudomonas aeruginosa, with minimum inhibitory concentrations ranging from 16 to 128 mu g/ml, comparable to standard antimicrobials. Two derivatives exhibited minimum inhibitory concentrations values against methicillin-resistant Staphylococcus aureus ranging from 64 to 128 mu g/ml. These compounds demonstrated both bacteriostatic and bactericidal effects, and antibiofilm features. Conclusion: The 6-AQs 19g and 19f showed a promising antimicrobial profile, indicating their potential as new therapeutic options.
- 14 October 2024
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 16 (21) , 2247-2261
Synthesis and evaluation of antibacterial and antibiofilm agents based on phenylamino-substituted 1,4-benzoquinones
Aim: This work describes the synthesis and antimicrobial evaluation of 6-aminated 1,4-benzoquinones (6-AQs) against seven resistant pathogens. Materials & methods: The 6-AQs, synthesized via a Michael addition reaction between bromoquinone and p-substituted anilines, were assessed for their antimicrobial activity through both in vitro and in silico analyses. Results: Bromoquinone and 6-AQs with electron-withdrawing groups demonstrated activity against Pseudomonas aeruginosa, with minimum inhibitory concentrations ranging from 16 to 128 mu g/ml, comparable to standard antimicrobials. Two derivatives exhibited minimum inhibitory concentrations values against methicillin-resistant Staphylococcus aureus ranging from 64 to 128 mu g/ml. These compounds demonstrated both bacteriostatic and bactericidal effects, and antibiofilm features. Conclusion: The 6-AQs 19g and 19f showed a promising antimicrobial profile, indicating their potential as new therapeutic options.
- Open Access
- 26 October 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (44) , 40241-40256
Theoretical Investigation of Regiodivergent Addition of Anilines and Phenolates to p-Benzoquinone Ring
Two different products were obtained by the regiodivergent reaction of benzoquinone derivatives with phenolates and anilines: 3-aryloxybenzoquinone and 2-phenylamino-3-bromobenzoquinone. Calculated density functional theory free energies of reaction values corroborate the experimental observation of the formation of the substitution product in the reaction with phenolates in acetonitrile and the product of addition/oxidation for the reaction with aniline in water. Calculated charges and Fukui functions are similar for C2 and C3 atoms, indicating an equal possibility to suffer a nucleophilic attack. The calculated energy barriers for nucleophilic attack steps indicated that the first steps of the substitution with phenolates and addition/oxidation with anilines are faster, which justifies the formation of the respective products. The natural bond order analysis for the transition states revealed that there is a strong interaction between lone pairs of N and O atoms and the pi C2C3* for the O -> C2 and N -> C3 attacks and a weak interaction for the O -> C3 and N -> C2 attacks, which also agrees with experimental observations.
- 26 October 2022
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 7 (44) , 40241-40256
Open AccessTheoretical Investigation of Regiodivergent Addition of Anilines and Phenolates to p-Benzoquinone Ring
Two different products were obtained by the regiodivergent reaction of benzoquinone derivatives with phenolates and anilines: 3-aryloxybenzoquinone and 2-phenylamino-3-bromobenzoquinone. Calculated density functional theory free energies of reaction values corroborate the experimental observation of the formation of the substitution product in the reaction with phenolates in acetonitrile and the product of addition/oxidation for the reaction with aniline in water. Calculated charges and Fukui functions are similar for C2 and C3 atoms, indicating an equal possibility to suffer a nucleophilic attack. The calculated energy barriers for nucleophilic attack steps indicated that the first steps of the substitution with phenolates and addition/oxidation with anilines are faster, which justifies the formation of the respective products. The natural bond order analysis for the transition states revealed that there is a strong interaction between lone pairs of N and O atoms and the pi C2C3* for the O -> C2 and N -> C3 attacks and a weak interaction for the O -> C3 and N -> C2 attacks, which also agrees with experimental observations.
- Open Access
- 3 March 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (3) , 309
Hybrids of Imatinib with Quinoline: Synthesis, Antimyeloproliferative Activity Evaluation, and Molecular Docking
Imatinib (IMT) is the first-in-class BCR-ABL commercial tyrosine kinase inhibitor (TKI). However, the resistance and toxicity associated with the use of IMT highlight the importance of the search for new TKIs. In this context, heterocyclic systems, such as quinoline, which is present as a pharmacophore in the structure of the TKI inhibitor bosutinib (BST), have been widely applied. Thus, this work aimed to obtain new hybrids of imatinib containing quinoline moieties and evaluate them against K562 cells. The compounds were synthesized with a high purity degree. Among the produced molecules, the inhibitor 4-methyl-N3-(4-(pyridin-3-yl)pyrimidin-2-yl)-N1-(quinolin-4-yl)benzene-1,3-diamine (2g) showed a suitable reduction in cell viability, with a CC50 value of 0.9 µM (IMT, CC50 = 0.08 µM). Molecular docking results suggest that the interaction between the most active inhibitor 2g and the BCR-ABL1 enzyme occurs at the bosutinib binding site through a competitive inhibition mechanism. Despite being less potent and selective than IMT, 2g is a suitable prototype for use in the search for new drugs against chronic myeloid leukemia (CML), especially in patients with acquired resistance to IMT.
- 3 March 2022
- Published by MDPI AG in Pharmaceuticals
- Vol. 15 (3) , 309
Open AccessHybrids of Imatinib with Quinoline: Synthesis, Antimyeloproliferative Activity Evaluation, and Molecular Docking
Imatinib (IMT) is the first-in-class BCR-ABL commercial tyrosine kinase inhibitor (TKI). However, the resistance and toxicity associated with the use of IMT highlight the importance of the search for new TKIs. In this context, heterocyclic systems, such as quinoline, which is present as a pharmacophore in the structure of the TKI inhibitor bosutinib (BST), have been widely applied. Thus, this work aimed to obtain new hybrids of imatinib containing quinoline moieties and evaluate them against K562 cells. The compounds were synthesized with a high purity degree. Among the produced molecules, the inhibitor 4-methyl-N3-(4-(pyridin-3-yl)pyrimidin-2-yl)-N1-(quinolin-4-yl)benzene-1,3-diamine (2g) showed a suitable reduction in cell viability, with a CC50 value of 0.9 µM (IMT, CC50 = 0.08 µM). Molecular docking results suggest that the interaction between the most active inhibitor 2g and the BCR-ABL1 enzyme occurs at the bosutinib binding site through a competitive inhibition mechanism. Despite being less potent and selective than IMT, 2g is a suitable prototype for use in the search for new drugs against chronic myeloid leukemia (CML), especially in patients with acquired resistance to IMT.
- 2 February 2022
- Published by Wiley in The Chemical Record
- Vol. 22 (3) , e202100251
Multicomponent Reactions (MCRs) with o‐Quinone Methides
This article presents a comprehensive overview of multicomponent reactions (MCRs) that proceed via ortho‐quinone methide intermediates (o‐QM) generated in the reaction medium. Examples of applications involving these highly reactive intermediates in organic synthesis and biological processes (e. g., biosynthetic pathways, prodrug cleavage and electrophilic capture of biological nucleophiles) are also described. QMs are often generated by eliminative processes of phenol derivatives or by photochemical reactions, including reversible generation in photochromic substances. This class of compounds can undergo various reaction types, including nucleophilic attack at the methide carbon, with subsequent rearomatization, and react with electron‐rich dienophiles in inverse‐electron demand hetero‐Diels‐Alder reactions. Its versatile reactivity has been explored in the context of cascade reactions for the construction of several classes of substances, including complex natural products.
- 2 February 2022
- Published by Wiley in The Chemical Record
- Vol. 22 (3) , e202100251
Multicomponent Reactions (MCRs) with o‐Quinone Methides
This article presents a comprehensive overview of multicomponent reactions (MCRs) that proceed via ortho‐quinone methide intermediates (o‐QM) generated in the reaction medium. Examples of applications involving these highly reactive intermediates in organic synthesis and biological processes (e. g., biosynthetic pathways, prodrug cleavage and electrophilic capture of biological nucleophiles) are also described. QMs are often generated by eliminative processes of phenol derivatives or by photochemical reactions, including reversible generation in photochromic substances. This class of compounds can undergo various reaction types, including nucleophilic attack at the methide carbon, with subsequent rearomatization, and react with electron‐rich dienophiles in inverse‐electron demand hetero‐Diels‐Alder reactions. Its versatile reactivity has been explored in the context of cascade reactions for the construction of several classes of substances, including complex natural products.
- Open Access
- 1 January 2022
- Published by Sociedade Brasileira de Quimica (SBQ) in Revista Virtual de Química
- Vol. 14 (5) , 824-842
Ceric Ammonium Nitrate (CAN): General Considerations, Synthesis and Applications in Organic Reactions
- 1 January 2022
- Published by Sociedade Brasileira de Quimica (SBQ) in Revista Virtual de Química
- Vol. 14 (5) , 824-842
Open AccessCeric Ammonium Nitrate (CAN): General Considerations, Synthesis and Applications in Organic Reactions
- 1 January 2022
- Published by Sociedade Brasileira de Quimica (SBQ) in Revista Virtual de Química
- Vol. 14 (4) , 563-586
L-Proline: Applications of a Versatile Amino Acid in the Areas of Medicinal Chemistry and Organic Synthesis
- 1 January 2022
- Published by Sociedade Brasileira de Quimica (SBQ) in Revista Virtual de Química
- Vol. 14 (4) , 563-586
L-Proline: Applications of a Versatile Amino Acid in the Areas of Medicinal Chemistry and Organic Synthesis
- Open Access
- 1 September 2021
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 17 (1) , 2260-2269
(Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia
The enzyme tyrosine kinase BCR-Abl-1 is the main molecular target in the treatment of chronic myeloid leukemia and can be competitively inhibited by tyrosine kinase inhibitors such as imatinib. New potential competitive inhibitors were synthesized using the (phenylamino)pyrimidine-pyridine (PAPP) group as a pharmacophoric fragment, and these compounds were biologically evaluated. The synthesis of twelve new compounds was performed in three steps and assisted by microwave irradiation in a 1,3-dipolar cycloaddition to obtain 1,2,3-triazole derivatives substituted on carbon C-4 of the triazole nucleus. All compounds were evaluated for their inhibitory activities against a chronic myeloid leukemia cell line (K562) that expresses the enzyme tyrosine kinase BCR-Abl-1 and against healthy cells (WSS-1) to observe their selectivity. Three compounds showed promising results, with IC50 values between 1.0 and 7.3 μM, and were subjected to molecular docking studies. The results suggest that such compounds can interact at the same binding site as imatinib, probably sharing a competitive inhibition mechanism. One compound showed the greatest interaction affinity for BCR-Abl-1 in the docking studies.
- 1 September 2021
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 17 (1) , 2260-2269
Open Access(Phenylamino)pyrimidine-1,2,3-triazole derivatives as analogs of imatinib: searching for novel compounds against chronic myeloid leukemia
The enzyme tyrosine kinase BCR-Abl-1 is the main molecular target in the treatment of chronic myeloid leukemia and can be competitively inhibited by tyrosine kinase inhibitors such as imatinib. New potential competitive inhibitors were synthesized using the (phenylamino)pyrimidine-pyridine (PAPP) group as a pharmacophoric fragment, and these compounds were biologically evaluated. The synthesis of twelve new compounds was performed in three steps and assisted by microwave irradiation in a 1,3-dipolar cycloaddition to obtain 1,2,3-triazole derivatives substituted on carbon C-4 of the triazole nucleus. All compounds were evaluated for their inhibitory activities against a chronic myeloid leukemia cell line (K562) that expresses the enzyme tyrosine kinase BCR-Abl-1 and against healthy cells (WSS-1) to observe their selectivity. Three compounds showed promising results, with IC50 values between 1.0 and 7.3 μM, and were subjected to molecular docking studies. The results suggest that such compounds can interact at the same binding site as imatinib, probably sharing a competitive inhibition mechanism. One compound showed the greatest interaction affinity for BCR-Abl-1 in the docking studies.